First patient dosed in phase III clinical program for APL-2 in geographic atrophy Sep. 13, 2018 No Comments
Phase I/II interim data on QR-110 in LCA10 support progression to phase II/III Sep. 6, 2018 No Comments
Kodiak completes enrollment in phase I study of KSI-301 in diabetic macular edema Sep. 4, 2018 No Comments
RSS